Kim Ji Hun, Kim Jin Hong, Hwang Joe Chul, Yoo Byung Moo, Moon Jong Ho, Lee Dong Ki, Kim Ho Gak, Cho Young Deok, Lee Don Haeng, Park Sang Heum
Hepatogastroenterology. 2013 Sep;60(126):1268-73. doi: 10.5754/hge11604.
BACKGROUND/AIMS: This study was designed to investigate clinicopathological features of patients who underwent endoscopic snare papillectomy (ESP) and to suggest how to manage patients after the procedure according to the pathological findings.
Seventy-nine patients underwent ESP for ampullary tumors in 7 tertiary medical centers in Korea. We retrospectively reviewed the medical records of each patient and analyzed the data.
Complete resection and complication rates of ESP were 76% and 21.7%, respectively; and pancreatitis rate was 11.5%. ESP-related mortality rate was 2.5% (n=2; 1 perforation and 1 pancreatitis). According to the pathological findings, endoscopic management was performed in 62/65 (95.4%) of low grade dysplasia (LGD) and 9/14 (64.3%) of high grade dysplasia (HGD)/cancer on pre-ESP; in 57/62 (92.0%) of LGD and 13/16 (81.3%) of HGD/cancer on ESP; and in 11/13(84.7%) of LGD and 0/6(0%) of HGD/cancer on follow-up biopsy. The rates of incomplete resection according to the pre-ESP pathological findings were 18.4% (12/65) in the LGD group and 50% (7/14) in the HGD/cancer group (p=0.033).
HGD or cancer required surgical management. Moreover, pre-procedural HGD/cancer was associated with a high rate of incomplete resection after ESP. Therefore, if the pre-ESP pathological results revealed HGD/cancer, a careful endoscopic follow-up with imaging study or an early surgical intervention should be considered.
背景/目的:本研究旨在调查接受内镜圈套乳头切除术(ESP)患者的临床病理特征,并根据病理结果提出术后患者的管理方法。
韩国7家三级医疗中心的79例患者因壶腹肿瘤接受了ESP。我们回顾性审查了每位患者的病历并分析了数据。
ESP的完全切除率和并发症发生率分别为76%和21.7%;胰腺炎发生率为11.5%。ESP相关死亡率为2.5%(n = 2;1例穿孔和1例胰腺炎)。根据病理结果,低级别异型增生(LGD)患者中62/65(95.4%)和高级别异型增生(HGD)/癌症患者中9/14(64.3%)在ESP前进行了内镜管理;LGD患者中57/62(92.0%)和HGD/癌症患者中13/16(81.3%)在ESP时进行了内镜管理;随访活检时LGD患者中11/13(84.7%)和HGD/癌症患者中0/6(0%)进行了内镜管理。根据ESP前病理结果,LGD组不完全切除率为18.4%(12/65),HGD/癌症组为50%(7/14)(p = 0.033)。
HGD或癌症需要手术治疗。此外,术前HGD/癌症与ESP后不完全切除率高相关。因此,如果ESP前病理结果显示HGD/癌症,应考虑仔细的内镜随访并进行影像学检查或早期手术干预。